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Prevents the last steps of xenophagy 
and disrupts antigen presentation
Mutated or knockout nef strain          
decreases viral replication and AIDS 
progression
 - Tat protein translates viral and cell proteins.     ER stress =     autophagy
 -    autophagy =    tat =    gag and nef = recovering normal autophagy
Proposed therapy
To counteract nef could be the best way to ght against HIV infection. The use of beclin-1 mimetic 
peptide would retain nef and block its mediated eects. The peptide will be based on the 267-299 
region of beclin-1(previously described by Shoji-Kawata, S. et al., Nature 2013) and will cover from 
55 to 121 nef residues, this represents over 30% of total viral protein. 
This peptide, combined with common ART (antiretroviral) cocktails would be able to stop HIV       
progression. Other autophagic enhancers could be added, but there is not enough description to 
ensure their ecacy.
Figure 3: Beclin-1 peptide (magenta) interaction with HIV 
nef protein (orange). GAPR1 (Golgi-Associated Plant Pa-
thogenesis-Related protein 1) structure (blue) is aligned 
with nef to point out that the interacting region is homo-
logous in both proteins. The models were obtained from 
SwissModel, builded from 4ddp (beclin-1 peptide), 3rea 
(nef) and 4aiw (GAPR-1) PDB codes. The interaction was 
determined by dierent docking servers and modeled by 
ROSIE server. The nef/GAPR-1 alignment was obtained 
with FATCAT server. Image designed with UCSF Chimera 
software.
Background Hypothesis Objectives and methods
Xenophagy response HIV disturbs autophagy
Bystander 
     cells
Latency
   Late
infection 
 stages
- env      autophagy and promotes cell death unless the cell become infected
- secreted tat downregulates autophagy to avoid premature degradation
- Viral genome transcription begins
- gag/LC3 and nef/beclin-1 co-localization trigger phagophore formation
HIV (human immunodeciency virus) is able to 
escape from the immune response and antiretrovi-
ral drugs. Despite this, HIV depends on its ability 
to avoid intrinsic cellular defenses. The presence 
of virulence factors against autophagy proves the 
essential role of xenophagy in HIV infection. Xe-
nophagy response is also implicated in antigen 
presentation extending its function to adaptive im-
munity.
To restore the xenophagy response dis-
rupted by viral infection could be a therapy 
to ght against HIV infection. The viral pro-
tein which seems to have a central role in this    
response is nef, mainly through nef/beclin-1 
interaction. Research of a drug to counteract 
this interaction could be the way to nd a     
therapy against HIV infection and AIDS          
(acquired immune deciency syndrome)       
progression.
The objective of the study is to dene the xenophagy response during HIV infec-
tion and propose a therapy strategy or investigation line. To achieve this, I have 
focused in recent publications and literature about the subject and bioinforma-
tic analyzing tools. Protein structure analysis and homology search were perfor-
med with pBLAST, FATCAT and T-Coee servers. Template construction was 
achieved with SwissModel software. Docking studies have been carried out with 
AutoDock 4.0, ClusPro, SwarmDock, ZDOCK and RossettaDock softwares. The           
modeling of the best clusters obtained from docking studies was performed 
with ROSIE server. The images were generated with UCSF Chimera software and 
Photoshop CS6.
beclin-1/nef interaction avoids autophagosome-lysosomal fusion. This        
avoids viral particles degradation and enhances gag processing and viral        
reproduction
Figure.1: Most xenophagy triggering signals converge in the inhibition of mTOR (mammalian target of rapamycin) or PRR (Pattern Re-
cognition Receptor) activation. This leads to the activation of PI3K complex (class III phosphatidylinositol-3-OH kinase) which triggers 
the autophagophore formation. The elongation begins guided by LC3. Finally it fuses with the lysosome through                 
LAMP-2/Rab7 and beclin-1/UVRAG interaction. Beclin-1 is involved in vesicle nucleation and autophagosomal maturation besides 
lysosomal fusion. Image designed with Photoshop CS6 software.
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HIV has got mechanisms to 
avoid xenophagy response. 
Blocking these mechanisms 
would diminish replication 
and also infection eciency 
of HIV. Investment on this in-
vestigation line would help 
us to obtain an ecient the-
rapy to treat HIV infection 
and AIDS symptoms.
In order to spread this theory 
and its argues the best way 
would be the publication in an 
high impact journal of this 
area. Also to contact resear-
chers to collaborate with them 
in further investigation. 
This work will be presented to 
Universitat Autònoma de Bar-
celona and will remain at their 
DDD (digital documents depo-
sit).
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Beclin-1 mimetic peptide is a great candidate to target nef
Autophagy 
disrutpion, 
mainly nef 
mediated, is
essential for 
an ecient HIV 
infection and 
replication
The nef/beclin-1
interaction 
covers over
30% of nef
 protein
The interaction 
with the peptide 
is stronger than 
with the full 
beclin-1
We are targeting 
a viral, non a 
host protein
The molecular
homology to 
hCG therapy,
currently 
approved, 
would facilitate 
the new therapy
acceptance
Positive reported 
results from in 
vitro and in vivo
assays
Figure 2: Global integrated scheme of the molecular cell 
cycle of HIV and xenophagy response against the infec-
tion. Viral entrance triggers autophagy response due to 
env mediated eects. Occurs mostly in an endocytic pa-
thway. This avoids fusion inhibitors but exposes the virus 
to lysosomal degradation. Viral genome keeps integra-
ted and transcriptionaly active until cell death. Infection 
can enter in a latency phase. In green frames, current tar-
gets in HIV antiretroviral therapy are highlighted.
 
Xenophagy response and its principal involved proteins 
in the dierent steps of the process are picted. Firstly   
xenophagy is initiated by cargo receptors that recognize 
foreign material. Then, autophagosome formation is 
mediated by LC3 and engulfs the foreign material. Fina-
lly, it fuses with the lysosome to degrade the content. Tat 
and nef proteins promote autophagy rst steps and nef 
also blocks autophagosome-lysosomal fusion through 
nef/beclin-1 interaction. This generates autophagoso-
me accumulation, which is useful for the virus for gag 
processing and for increasing viral protein ux to cyto-
plasmatic membrane. The downregulation of autopha-
gosome formation also prevents MHC (major histocom-
patibility complex) presentation and the initiation of 
adaptive immune response. MHC presentation is also 
disrupted by nef protein through disruption of Golgi’s 
vesicle trac. TLR-7 (toll-like receptor) has a role in HIV 
recognition and could start antiviral response through 
IFN-α (interferon) transcription among others. 
Image designed with Photoshop CS6 software.
Proteins involved in
autophagy disruption
Necessary for transcription, also there 
are drugs to counteract its eects
gag/LC3-II interaction occurs in a nef 
dependent manner
Autophagy induction will occur wether 
there is an infection or not
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